Disparities and therapeutic advances in cystic fibrosis.

Abstract excerpt

Cystic fibrosis (CF) has seen a multitude of therapeutic advances targeting its downstream effects. This has led to a steady increase in survival over the past few decades. The recent development of disease-modifying drugs targeting the underlying CFTR mutation has revolutionized treatment for CF. Despite these advances, individuals with CF who are racial and ethnic minorities, from low socioeconomic status, or...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mutation
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator